Correlation Between Verrica Pharmaceuticals and Orgenesis
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Orgenesis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Orgenesis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Orgenesis, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Orgenesis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Orgenesis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Orgenesis.
Diversification Opportunities for Verrica Pharmaceuticals and Orgenesis
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Verrica and Orgenesis is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Orgenesis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orgenesis and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Orgenesis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orgenesis has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Orgenesis go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Orgenesis
If you would invest 122.00 in Orgenesis on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Orgenesis or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 4.55% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. Orgenesis
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| Orgenesis |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Verrica Pharmaceuticals and Orgenesis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and Orgenesis
The main advantage of trading using opposite Verrica Pharmaceuticals and Orgenesis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Orgenesis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will offset losses from the drop in Orgenesis' long position.| Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
| Orgenesis vs. Tff Pharmaceuticals | Orgenesis vs. Quoin Pharmaceuticals Ltd | Orgenesis vs. Aerovate Therapeutics | Orgenesis vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |